Eurostart Eureka European grant

Published on


Syncom has been awarded a grant for the development of novel enantiomerically pure functionalized polyhydroxyalkanoates (PHA’s). The resulting chiral 3-hydroxycarboxylic acids will be utilized as chiral synthons for fine chemistry (pharma) and as monomers in order to produce innovative homo-polymers and co-polymers for high-value markets. Syncom will seek for opportunities to use the chiral synthons in drug discovery and improved synthesis of new and existing drugs, including generics. In this project Syncom partners with Biopolis (Spain) and Polyvation (The Netherlands).


Do you have a question?

Do you want to stay updated on Syncom’s activities? Follow us on LinkedIn or contact us here.